BRIEF-Galapagos reports first dosing of a patient in selection phase 2b/3 study with filgotinib in ulcerative colitis
December 08, 2016 at 16:15 PM EST
* Reports first dosing of a patient in selection phase 2b/3 study with filgotinib in ulcerative colitis
